HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure

Item
http://www.wikidata.org/entity/Q34781706
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter TrialPredicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithmShould viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settingsHIV-1 persistent viremia is frequently followed by episodes of low-level viremia.Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.Determinants of virological failure and antiretroviral drug resistance in Mozambique.Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.Development and characterization of a long-acting nanoformulated abacavir prodrugHIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-la
P2860

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure

Item
http://www.wikidata.org/entity/Q34781706
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV drug resistance detected d ...... h subsequent virologic failure
@ast
HIV drug resistance detected d ...... h subsequent virologic failure
@en
HIV drug resistance detected d ...... h subsequent virologic failure
@nl
type
label
HIV drug resistance detected d ...... h subsequent virologic failure
@ast
HIV drug resistance detected d ...... h subsequent virologic failure
@en
HIV drug resistance detected d ...... h subsequent virologic failure
@nl
prefLabel
HIV drug resistance detected d ...... h subsequent virologic failure
@ast
HIV drug resistance detected d ...... h subsequent virologic failure
@en
HIV drug resistance detected d ...... h subsequent virologic failure
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
HIV drug resistance detected d ...... h subsequent virologic failure
@en
P2093
P2860
P304
P31
P356
10.1097/QAD.0000000000000203
P407
P433
P478
P50
P577
P698
P921
P932